[Molecular mechanisms of thrombolytic therapy].
D004789:Enzyme Activation; D005337:Fibrin / Q000378:metabolism; D005341:Fibrinolysin / Q000502:physiology; D005342:Fibrinolysis; D006801:Humans; D008970:Molecular Weight; D010958:Plasminogen / Q000378:metabolism / Q000502:physiology; D010960:Plasminogen Activators / Q000302:isolation & purification / Q000494:pharmacology; D013300:Streptokinase / Q000494:pharmacology; D010959:Tissue Plasminogen Activator / Q000502:physiology / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000302:isolation & purification / Q000494:pharmacology; D000979:alpha-2-Antiplasmin / Q000502:physiology
D000979:alpha-2-Antiplasmin; D005337:Fibrin; D010958:Plasminogen; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator
Mécanismes moléculaires de la thérapeutique thrombolytique.